Table 2.
Fibulin-5-siRNA screening.
| Group | Internal reference | Ct | ΔCt | ΔΔCt | 2-ΔΔCt |
|---|---|---|---|---|---|
| A | 11.94 | 15.75 | 3.81 | 0.00 | 1.00 |
| B | 12.13 | 16.05 | 3.91 | 0.10 | 0.95 |
| C | 13.98 | 17.72 | 3.73 | -0.08 | 1.09 |
| D | 12.44 | 19.09 | 6.64 | 2.83 | 0.15 |
| E | 11.76 | 16.35 | 4.58 | 0.78 | 0.59 |
| F | 12.53 | 16.55 | 4.03 | 0.22 | 0.87 |
A: blank group; B: Lipofectamine 2000 only; C: negative siRNA control group; D: Fibulin-5-siRNA-1; E: Fibulin-5-siRNA-2; F: Fibulin-5-siRNA-3. ΔCt = target gene Ct − internal reference Ct. ΔΔCt is the target gene ΔCt in the experimental sample minus target gene ΔCt in the reference sample; assuming the amplification efficiency of PCR is close to 100%, the relative sample template amount = 2 − ΔΔCt.